Hims & Hers Health Annual Stockholders Meeting Results

Hims & Hers Health ( (HIMS) ) just unveiled an update.

On June 12, 2025, Hims & Hers Health, Inc. conducted its Annual Meeting of Stockholders where three proposals were voted on. The election of eight directors, the ratification of KPMG LLP as the independent registered public accounting firm, and the advisory approval of executive compensation were all passed, reflecting shareholder support for the company’s governance and financial strategies.

The most recent analyst rating on (HIMS) stock is a Hold with a $40.00 price target. To see the full list of analyst forecasts on Hims & Hers Health stock, see the HIMS Stock Forecast page.

Spark’s Take on HIMS Stock

According to Spark, TipRanks’ AI Analyst, HIMS is a Outperform.

Hims & Hers Health scores highly due to strong financial performance and positive earnings call sentiment, indicating robust revenue growth and strategic expansion plans. While technical indicators show bullish momentum, the high valuation and beta introduce some risks. Overall, the company’s growth prospects are favorable, but investors should be mindful of potential volatility and valuation concerns.

To see Spark’s full report on HIMS stock, click here.

More about Hims & Hers Health

Hims & Hers Health, Inc. operates in the telehealth industry, providing a range of health and wellness products and services. The company focuses on offering personalized health solutions through its digital platform.

Average Trading Volume: 38,900,009

Technical Sentiment Signal: Buy

Current Market Cap: $13.38B

For a thorough assessment of HIMS stock, go to TipRanks’ Stock Analysis page.